Cytori Therapeutics (NASDAQ:CYTX) will provide a webcast of its
corporate presentation at two upcoming investor conferences. The Company
will present at the Noble Financial Equity Conference on Monday, June 8,
2009 at 8:05 AM EDT and at the Needham Life Sciences Conference on
Wednesday, June 10, 2009 at 9:00 AM EDT.
The webcasts will be available live and by replay and will be accessible
under “Events & Webcasts” in the Investor Relations section of the
Company’s website, www.cytoritx.com.
About Cytori
Cytori develops and globally commercializes regenerative medicine
technologies, which provide real-time, point-of-care access to clinical
grade regenerative cells. Our technology is incorporated into two
product families. The Celution®-related products are sold throughout
Europe and Asia primarily into the cosmetic and reconstructive surgery
market and are under evaluation by the U.S. FDA. Our StemSource®
products are sold globally for cell banking and research applications.
We are also developing additional clinical uses of our technology for
the treatment of multiple medical conditions, including cardiovascular
disease, urinary tract disorders, and wound related conditions. To
commercialize our technology, Cytori has partnered with global and
regional leaders in healthcare such as Olympus Corporation, GE
Healthcare, and Green Hospital Supply. www.cytoritx.com
Cytori Therapeutics
Megan McCormick, 858-875-5279
mmccormick@cytoritx.com
